Influence of first-pass effect on availability of drugs on oral administration.
about
Species differences in the disposition and metabolism of camazepamOral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin patternSingle- and multiple-dose pharmacokinetics of nefiracetam, a new nootropic agent, in healthy volunteers.Oral prednisone for chronic active liver disease: dose responses and bioavailability studies.The pharmacokinetics of ephedrine after oral dosage in asthmatics receiving acute and chronic treatmentParacetamol disposition in normal subjects and in patients treated with antiepileptic drugs.Reduction of oral bioavailability of lignocaine by induction of first pass metabolism in epileptic patients.Effect of food on the bioavailability of labetalol.Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.Methods for the analysis of intestinal functionOral pharmacokinetics of the acidic drugs, diclofenac and sulfamonomethoxine in male Shiba goatsApplication of Caco-2 cell line in herb-drug interaction studies: current approaches and challengesEffects of zinc deuteroporphyrin bis glycol on newborn mice after heme loadingMetabolism, pharmacokinetics, tissue distribution, and stability studies of the prodrug analog of an anti-hepatitis B virus dinucleoside phosphorothioate.HPLC analysis of in vivo intestinal absorption and oxidative metabolism of salicylic acid in the rat.Bioactivity of a modified human Glucagon-like peptide-1.Prediction of systemic availability from plasma-level data after oral drug administration.Methods for obtaining drug time course data from individual small laboratory animals: serial microblood sampling and assay.Applications of a recirculatory stochastic pharmacokinetic model: limitations of compartmental models.The disposition of timolol in man.Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat.Which beta blocker?Physiologic pharmacokinetic models: relevance, experience, and future trends.Applicability of different types of models in health and disease.Estimation of biological availability after oral drug administration when the drug is eliminated by urinary excretion and metabolism.Biliary excretion of metals.Hepatic clearance of propranolol in dogsMetabolic and hematological consequences of dietary deoxynivalenol interacting with systemic Escherichia coli lipopolysaccharide.Oral pharmacokinetics of acetaminophen to evaluate gastric emptying profiles of Shiba goatsPartial metabolic clearances as determinants of the oral bioavailability of propranolol.Stereospecific assay of nicoumalone: application to pharmacokinetic studies in man.Pharmacokinetics of compound 58-112, a potential skeletal muscle relaxant, in man.The pharmacokinetics and bioavailability of clemastine and phenylpropanolamine in single-component and combination formulations.Individual variability in response to haloperidol.A general equation for the ratio of the areas below the blood or plasma concentration time-curves following intravenous and oral drug administration and its application to inter-subject variations in drug elimination.Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect."First-pass" metabolism of paracetamol in rat liver.Pharmacokinetic studies on the selective beta1-receptor antagonist metoprolol in man.Absolute bioavailability and stereoselective pharmacokinetics of doxepin.The utility of pharmacokinetics to the pharmaceutical industry.
P2860
Q28282309-AA7048CF-18F5-414A-B127-237FD5052668Q28397238-3CBCFA0E-570B-4E99-98C4-DBE367AE8334Q34245189-AEC3BDA9-6046-4452-BB1D-F7AFA882EA9AQ34475234-66150E71-5F3A-4092-80AE-7A41814319C8Q34515052-E26FA02E-F7D4-4F8A-BC90-680CF51ECBE3Q34516840-D394CF1E-7AF3-421C-84B5-3E8B1F0688FEQ34517822-84555E0F-C0E0-4DD6-B4E4-30A24551DB1DQ34518765-DD3635C4-F75C-468A-B6A5-6302D2BB8A55Q34518926-6D17F8FD-3F12-43E3-86DD-AE7259EFC4F3Q35135364-543CF1C0-821E-4E3E-A617-52EE1A9B9515Q35147092-38369788-A1BF-4686-A74A-C41D266D67EEQ35164876-1EA2BE06-5BCA-4D48-8375-1B8917B8FCD3Q35291583-A35020BD-461B-4F5E-B9F7-D65E5BAC80FCQ35913071-1F5A81D2-8DA1-4E59-9187-6E259853B4EEQ36063425-D2E99F6A-4119-4164-A77D-3394581BE740Q36267715-F24B318D-61EC-4C23-90E7-83BCD589D0D6Q36504989-0E734C44-709A-4C31-8B70-C0EDF4422B6BQ36733549-CF87885A-09BE-4CCD-8E90-36D8507CD795Q37706410-814F99D3-CE8C-46E8-9EC1-3A1E5936EA48Q39176333-E75C796B-3203-4584-B592-9E9D9F9B1B66Q39278948-649F89CA-E76D-4899-867F-49324FE42BC1Q40089857-CD5683ED-0967-4B04-842E-A9959D294106Q40182427-0863C66C-C04F-4804-B9F8-F3321078DC17Q40182441-CF9D226D-2DCA-44B4-9738-9460C7056806Q40322013-24B45839-9185-45F5-B060-A7A46AB7CF8BQ40668154-6F632D6B-3CB6-4FAA-9770-E47C6BBA30A6Q41814594-18090AFE-DCFF-4782-8DBF-7E5483E422A2Q41858144-C66AE2E7-FE85-4149-A6CB-6E5970B74AA7Q41990354-788BEADE-6EE4-4F22-B4C7-5535D27DA76DQ42015699-E8E2F5CF-8A18-46BA-926D-4688A166E455Q42135140-78B8E966-3401-48BA-8DE6-27606CDCBFF6Q42255697-2EFBE9EF-3674-4FBF-B53F-9CDDAEE6D685Q42552391-5A46FBC2-9098-4249-B836-CECF25E3F416Q42816775-6183B8BA-23AA-45B9-9F3A-53722CFF7034Q43241838-2D9409C6-8BAA-41DB-B979-543A645794D1Q43253460-EE8ECBB0-F6A0-4DA2-A5D0-2EE86BA8F94FQ43493660-B19B49A3-F90B-4EDD-892C-CD49E4AD5A57Q43712645-3D39EECB-025E-48C0-BB0A-DAA69A0E5E18Q44090146-6E8153B9-24AD-4222-A0CE-2F2D2939096EQ44546055-45AD644D-5FD2-4D46-BB0A-A2B56D0F7049
P2860
Influence of first-pass effect on availability of drugs on oral administration.
description
1971 nî lūn-bûn
@nan
1971 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1971 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1971年の論文
@ja
1971年論文
@yue
1971年論文
@zh-hant
1971年論文
@zh-hk
1971年論文
@zh-mo
1971年論文
@zh-tw
1971年论文
@wuu
name
Influence of first-pass effect on availability of drugs on oral administration.
@ast
Influence of first-pass effect on availability of drugs on oral administration.
@en
Influence of first-pass effect on availability of drugs on oral administration.
@nl
type
label
Influence of first-pass effect on availability of drugs on oral administration.
@ast
Influence of first-pass effect on availability of drugs on oral administration.
@en
Influence of first-pass effect on availability of drugs on oral administration.
@nl
prefLabel
Influence of first-pass effect on availability of drugs on oral administration.
@ast
Influence of first-pass effect on availability of drugs on oral administration.
@en
Influence of first-pass effect on availability of drugs on oral administration.
@nl
P2093
P356
P1476
Influence of first-pass effect on availability of drugs on oral administration.
@en
P2093
P304
P356
10.1002/JPS.2600600909
P407
P577
1971-09-01T00:00:00Z